Events

February 26-28, 2020 – Crowne Plaza Times Square, New York City, NY
New Scientific Frontiers in Cell Therapies for Solid Tumors

February 24-27, 2020 – Hotel Novotel London West, London, UK
Translational Strategies to Prevent Toxicity

December 9-13, 2019 – Marriott Marquis San Diego, San Diego, CA
TCR-mimic Antibodies against Intracellular Target for Cancer Immunotherapy: Targeting Alpha-fetoprotein (AFP) in Advanced Hepatocellular Carcinoma

December 7-10, 2019 – Orange County Convention Center (OCCC), Orlando, FL
Poster Presentation – First-in-Human Study of ET019003, a Next Generation Anti-CD19 T-Cell Therapy, in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)

December 2-5, 2019 – San Francisco Airport Marriott Waterfront, San Francisco, CA
TCR-mimic Antibody Redirected T-cell Therapy for Solid Tumors

November 6-10, 2019 – Gaylord National Hotel & Convention Center, National Harbor, MD
Poster Presentation – ET140202 T-cell Therapy for the Treatment of Liver Cancer is Built upon a Novel Antibody-T cell Receptor (AbTCR) ARTEMIS” T-cell Platform

September 28, 2019 – Santa Clara Convention Center, Santa Clara, CA
Panel Discussion – The Promise of Cell Therapy

September 17-18, 2019 – Crowne Plaza San Francisco Airport, San Francisco, CA
Antibody-TCR (AbTCR) T-cell Therapy for Solid and Hematological Malignancies

September 10-13, 2019 – Seaport Hotel & WTC, Boston, MA
ET140202 T-Cell Therapy in Advanced Liver Cancer (Hepatocellular Carcinoma)
A Novel Antibody-T cell Receptor (AbTCR) ARTEMIS” T-cell Platform Designed to Prevent T-Cell Hyperactivation

June 18-20, 2019 – Shanghai, China
Antibody-TCR ARTEMIS” T-cell Therapy for Solid Tumors & Hematological Malignancies